This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Harte-Hanks (HHS) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Harte-Hanks (HHS) delivered earnings and revenue surprises of 30% and 0.91%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Integral Ad Science (IAS) Q3 Earnings Top Estimates
by Zacks Equity Research
Integral Ad Science (IAS) delivered earnings and revenue surprises of 25% and 3.34%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Harte-Hanks (HHS) Flat As Market Gains: What You Should Know
by Zacks Equity Research
Harte-Hanks (HHS) concluded the recent trading session at $6.98, signifying no movement from its prior day's close.
Harte-Hanks (HHS) Stock Moves -0.84%: What You Should Know
by Zacks Equity Research
The latest trading day saw Harte-Hanks (HHS) settling at $7.11, representing a -0.84% change from its previous close.
Harte-Hanks (HHS) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Harte-Hanks (HHS) closed the most recent trading day at $7.30, moving -1.35% from the previous trading session.
Harte-Hanks (HHS) Stock Moves -0.68%: What You Should Know
by Zacks Equity Research
The latest trading day saw Harte-Hanks (HHS) settling at $7.25, representing a -0.68% change from its previous close.
Harte-Hanks (HHS) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the most recent trading session, Harte-Hanks (HHS) closed at $7.30, indicating a -0.41% shift from the previous trading day.
Harte-Hanks (HHS) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Harte-Hanks (HHS) closed at $7.31, marking a -0.41% move from the previous day.
Harte-Hanks (HHS) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the latest trading session, Harte-Hanks (HHS) closed at $7.44, marking a +1.64% move from the previous day.
Harte-Hanks (HHS) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
In the most recent trading session, Harte-Hanks (HHS) closed at $7.54, indicating a +0.94% shift from the previous trading day.
Harte-Hanks (HHS) Q2 Earnings Beat Estimates
by Zacks Equity Research
Harte-Hanks (HHS) delivered earnings and revenue surprises of 433.33% and 3.36%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Harte Hanks (HHS) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Harte Hanks' (HHS) revenues and earnings are likely to have declined year over year in the second quarter of 2024.
Earnings Preview: Harte-Hanks (HHS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Harte-Hanks (HHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stagwell (STGW) Q2 Earnings Miss Estimates
by Zacks Equity Research
Stagwell (STGW) delivered earnings and revenue surprises of -17.65% and 1.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Harte-Hanks (HHS) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
In the closing of the recent trading day, Harte-Hanks (HHS) stood at $8.44, denoting a +0.24% change from the preceding trading day.
Harte-Hanks (HHS) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Harte-Hanks (HHS) settling at $8.40, representing a -0.94% change from its previous close.
Harte-Hanks (HHS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the most recent trading session, Harte-Hanks (HHS) closed at $8.33, indicating a +0.48% shift from the previous trading day.
Harte-Hanks (HHS) Stock Moves -0.48%: What You Should Know
by Zacks Equity Research
Harte-Hanks (HHS) closed the most recent trading day at $8.38, moving -0.48% from the previous trading session.
Is Harte Hanks (HHS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Industry Outlook Highlights Omnicom, WPP and Harte Hanks
by Zacks Equity Research
Omnicom, WPP and Harte Hanks are part of the Zacks Industry Outlook article.
3 Advertising & Marketing Stocks to Watch Amid Industry Woes
by Zacks Equity Research
The Zacks Advertising and Marketing industry is expected to gradually reach the pre-pandemic healthy levels with increased service activities. OMC, WPP and HHS are likely to ride on the digital marketing surge and client-centric strategies.
5 Stocks With Recent Price Strength to Boost Your Portfolio
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are KNOP, AMSC, HHS, ATGE, GPRK.
Harte-Hanks (HHS) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Harte-Hanks (HHS) Soars 6.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Harte-Hanks (HHS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Best Value Stocks to Buy for June 27th
by Zacks Equity Research
M, R and HHS made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 27, 2024.